Fig. 2

Analysis of total cholesterol (TC) after NAC and overall survival (OS) in patients with all breast cancer subtypes. OS was not significantly different between patients with normal TC and high TC levels among all breast cancer (P = 0.606, log-rank) (a). OS was not significantly different between patients with normal TC and high TC levels in luminal breast cancer (P = 0.916, log-rank) (b). OS was not significantly different between patients with normal TC and high TC levels in luminal-human-epidermal growth factor receptor 2 (HER2)-enriched breast cancer (P = 0.387, log-rank) (c). OS was not significantly different between patients with normal TC and high TC levels in HER2-enriched breast cancer (P = 0.148, log-rank) (d). Patients with high TC after NAC had significantly better OS of triple-negative breast cancer (P = 0.014, log-rank) (e)